DETECTION OF ANTI-HIV ANTIBODIES

被引：0
|
作者：
COUROUCE, AM
机构：
来源：
BIOFUTUR | 1994年 / 135期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：26 / &
相关论文
共 50 条
  • [41] PREVALENCE OF ANTI-HIV ANTIBODIES IN SUBJECTS WHO RECEIVED IMMUNOGLOBULINS
    BREMARDOURY, C
    COUROUCE, AM
    BADILLET, M
    HUCHET, J
    CHAPELLE, A
    BIERLING, P
    SCHULLER, E
    JULLIEN, AM
    HABIBI, B
    PRESSE MEDICALE, 1987, 16 (40): : 2013 - &
  • [42] Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation
    Mouquet, Hugo
    Scheid, Johannes F.
    Zoller, Markus J.
    Krogsgaard, Michelle
    Ott, Rene G.
    Shukair, Shetha
    Artyomov, Maxim N.
    Pietzsch, John
    Connors, Mark
    Pereyra, Florencia
    Walker, Bruce D.
    Ho, David D.
    Wilson, Patrick C.
    Seaman, Michael S.
    Eisen, Herman N.
    Chakraborty, Arup K.
    Hope, Thomas J.
    Ravetch, Jeffrey V.
    Wardemann, Hedda
    Nussenzweig, Michel C.
    NATURE, 2010, 467 (7315) : 591 - U117
  • [43] INHIBITION OF ELISA TEST FOR ANTI-HIV ANTIBODIES BY RHEUMATOID FACTORS
    REVIRON, M
    JANVIER, D
    NOEL, L
    BONNET, M
    REVIRON, J
    PRESSE MEDICALE, 1987, 16 (18): : 912 - 912
  • [44] Long-term Delivery of Anti-HIV Monoclonal Antibodies
    Martinez-Navio, Jose M.
    Fuchs, Sebastian P.
    Pantry, Shara N.
    Duggan, Natasha N.
    Lauer, William A.
    Rakasz, Eva G.
    Keele, Brandon F.
    Lifson, Jeffrey D.
    Gao, Guangping
    Desrosiers, Ronald C.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 : 51 - 51
  • [45] ANTI-HIV ANTIBODIES SCREENING-TESTS AND SEROLOGY DIFFICULTIES
    COUROUCE, AM
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 1994, 1 (05) : 387 - 395
  • [46] AAV-Mediated Delivery of Anti-HIV Antibodies to the CNS
    Martinez-Navio, Jose M.
    Fuchs, Sebastian P.
    Mendes, Desiree E.
    Muniz, Claudia P. Ramos
    Rakasz, Eva G.
    Gao, Guangping
    Lifson, Jeffrey D.
    Desrosiers, Ronald C.
    MOLECULAR THERAPY, 2022, 30 (04) : 31 - 31
  • [47] Special Lecture: Engineering anti-HIV antibodies for optimal control of HIV infection
    Ravetch, Jeffrey
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 74 : 60 - 60
  • [48] Contribution of VH replacement products to the generation of anti-HIV antibodies
    Liao, Hongyan
    Guo, Jun-tao
    Lange, Miles D.
    Fan, Run
    Zemlin, Michael
    Su, Kaihong
    Guan, Yongjun
    Zhang, Zhixin
    CLINICAL IMMUNOLOGY, 2013, 146 (01) : 46 - 55
  • [49] PREVALENCE OF ANTI-HIV ANTIBODIES (HUMAN-IMMUNODEFICIENCY-VIRUS)
    MUCHINIK, G
    PICCHIO, G
    SCAGLIONE, C
    CAHN, P
    PEREZ, H
    CASIRO, A
    LIVELLARA, B
    MARTIN, E
    QUINTANA, J
    ANSELMO, A
    BOUZAS, MB
    BIANCO, RP
    PINTO, MT
    FERNANDEZ, E
    TABORDA, M
    MORISOLI, L
    FAY, O
    MEDICINA-BUENOS AIRES, 1987, 47 (06) : 569 - 569
  • [50] Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation
    Hugo Mouquet
    Johannes F. Scheid
    Markus J. Zoller
    Michelle Krogsgaard
    Rene G. Ott
    Shetha Shukair
    Maxim N. Artyomov
    John Pietzsch
    Mark Connors
    Florencia Pereyra
    Bruce D. Walker
    David D. Ho
    Patrick C. Wilson
    Michael S. Seaman
    Herman N. Eisen
    Arup K. Chakraborty
    Thomas J. Hope
    Jeffrey V. Ravetch
    Hedda Wardemann
    Michel C. Nussenzweig
    Nature, 2010, 467 : 591 - 595
12345